| Antibiotic susceptibility determination within one cell cycle at single-bacterium level by stimulated Raman metabolic imaging W Hong, CW Karanja, NS Abutaleb, W Younis, X Zhang, MN Seleem, ... Analytical chemistry 90 (6), 3737-3743, 2018 | 104 | 2018 |
| Rapid Determination of Antimicrobial Susceptibility by Stimulated Raman Scattering Imaging of D2O Metabolic Incorporation in a Single Bacterium M Zhang, W Hong, NS Abutaleb, J Li, PT Dong, C Zong, P Wang, ... Advanced Science 7 (19), 2001452, 2020 | 88 | 2020 |
| Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris HE Eldesouky, X Li, NS Abutaleb, H Mohammad, MN Seleem International journal of antimicrobial agents 52 (6), 754-761, 2018 | 88 | 2018 |
| Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci A AbdelKhalek, NS Abutaleb, KA Elmagarmid, MN Seleem Scientific reports 8 (1), 8353, 2018 | 67 | 2018 |
| Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus J Kaur, X Cao, NS Abutaleb, A Elkashif, AL Graboski, AD Krabill, ... Journal of medicinal chemistry 63 (17), 9540-9562, 2020 | 64 | 2020 |
| Antibacterial and antivirulence activities of auranofin against Clostridium difficile A AbdelKhalek, NS Abutaleb, H Mohammad, MN Seleem International journal of antimicrobial agents 53 (1), 54-62, 2019 | 62 | 2019 |
| Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE) A AbdelKhalek, NS Abutaleb, H Mohammad, MN Seleem PloS one 13 (6), e0199710, 2018 | 56 | 2018 |
| Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci H Mohammad, A AbdelKhalek, NS Abutaleb, MN Seleem International journal of antimicrobial agents 51 (6), 897-904, 2018 | 54 | 2018 |
| Structure–Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae CS Hewitt, NS Abutaleb, AEM Elhassanny, A Nocentini, X Cao, DP Amos, ... ACS infectious diseases 7 (7), 1969-1984, 2021 | 53 | 2021 |
| Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ... European Journal of Medicinal Chemistry 186, 111850, 2020 | 53 | 2020 |
| From phenylthiazoles to phenylpyrazoles: broadening the antibacterial spectrum toward carbapenem-resistant bacteria A Hammad, NS Abutaleb, MM Elsebaei, AB Norvil, M Alswah, AO Ali, ... Journal of medicinal chemistry 62 (17), 7998-8010, 2019 | 45 | 2019 |
| Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity A Kotb, NS Abutaleb, MA Seleem, M Hagras, H Mohammad, A Bayoumi, ... European journal of medicinal chemistry 151, 110-120, 2018 | 43 | 2018 |
| Flexible microneedle array patch for chronic wound oxygenation and biofilm eradication I Woodhouse, S Nejati, V Selvamani, H Jiang, S Chittiboyina, J Grant, ... ACS Applied Bio Materials 4 (7), 5405-5415, 2021 | 42 | 2021 |
| Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA) MM Elsebaei, H Mohammad, M Abouf, NS Abutaleb, YA Hegazy, A Ghiaty, ... European journal of medicinal chemistry 148, 195-209, 2018 | 41 | 2018 |
| N-(1, 3, 4-oxadiazol-2-yl) benzamide analogs, bacteriostatic agents against methicillin-and vancomycin-resistant bacteria C Opoku-Temeng, GA Naclerio, H Mohammad, N Dayal, NS Abutaleb, ... European Journal of Medicinal Chemistry 155, 797-805, 2018 | 40 | 2018 |
| In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci NS Abutaleb, AEM Elhassanny, DP Flaherty, MN Seleem PeerJ 9, e11059, 2021 | 33 | 2021 |
| In Vivo Antibacterial Activity of Acetazolamide NS Abutaleb, A Elkashif, DP Flaherty, MN Seleem Antimicrobial Agents and Chemotherapy 65 (4), 10.1128/aac. 01715-20, 2021 | 32 | 2021 |
| Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection NS Abutaleb, MN Seleem Scientific reports 10 (1), 7701, 2020 | 32 | 2020 |
| Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of Clostridioides difficile infections NS Abutaleb, MN Seleem Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 02115-19, 2020 | 30 | 2020 |
| Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity M Hagras, NS Abutaleb, AO Ali, JA Abdel-Aleem, MM Elsebaei, ... ACS infectious diseases 4 (12), 1679-1691, 2018 | 30 | 2018 |
Mohamed N. SeleemTyler and Frances Young Endowed Chair of Bacteriology, Director, Center for One Health ResearchVerified email at vt.edu
